00L/PRD_000618

MOL-126

Created:	2010-10-28
Last modified:	2024-09-27

00L/PRD_000618 is described in the Biologically Interesting Molecule Reference Dictionary (BIRD).

The representative PDB ID is 1A5G.

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	84
Chiral Atom Count	4
Bond Count	87
Aromatic Bond Count	12

2D diagram of 00L

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	MOL-126
Synonyms	MOL-126
Systematic Name (OpenEye OEToolkits)	(3S,6S,9S)-6-azanyl-N-[(2S,3S)-6-carbamimidamido-2-hydroxy-1-oxo-1-(phenethylamino)hexan-3-yl]-5-oxo-6-(phenylmethyl)-2,3,7,8-tetrahydro-1H-pyrazolo[1,2-a]pyridazine-3-carboxamide
Formula	C₃₀ H₄₂ N₈ O₄
Molecular Weight	578.706
Type	PEPTIDE-LIKE

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	O=C(NCCc1ccccc1)C(O)C(NC(=O)C3N2C(=O)C(N)(CCN2CC3)Cc4ccccc4)CCCNC(=[N@H])N
SMILES	CACTVS	3.385	NC(=N)NCCC[CH](NC(=O)[CH]1CCN2CC[C](N)(Cc3ccccc3)C(=O)N12)[CH](O)C(=O)NCCc4ccccc4
SMILES	OpenEye OEToolkits	1.7.5	c1ccc(cc1)CCNC(=O)C(C(CCCNC(=N)N)NC(=O)C2CCN3N2C(=O)C(CC3)(Cc4ccccc4)N)O
Canonical SMILES	CACTVS	3.385	NC(=N)NCCC[C@H](NC(=O)[C@@H]1CCN2CC[C@@](N)(Cc3ccccc3)C(=O)N12)[C@H](O)C(=O)NCCc4ccccc4
Canonical SMILES	OpenEye OEToolkits	1.7.5	[H]/N=C(\N)/NCCC[C@@H]([C@@H](C(=O)NCCc1ccccc1)O)NC(=O)[C@@H]2CCN3N2C(=O)[C@@](CC3)(Cc4ccccc4)N
InChI	InChI	1.03	InChI=1S/C30H42N8O4/c31-29(32)35-16-7-12-23(25(39)27(41)34-17-13-21-8-3-1-4-9-21)36-26(40)24-14-18-37-19-15-30(33,28(42)38(24)37)20-22-10-5-2-6-11-22/h1-6,8-11,23-25,39H,7,12-20,33H2,(H,34,41)(H,36,40)(H4,31,32,35)/t23-,24-,25-,30+/m0/s1
InChIKey	InChI	1.03	BCHJOEWNJFXZEK-DNHJLFCISA-N

Related Resource References

Resource Name	Reference
PubChem	5287788

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.